Search

Search Constraints

You searched for: Author/Creator Gottesman, Gary S

Search Results

1. Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial. Issue 10189 (15th June 2019)

3. PHEX 3′‐UTR c.*231A>G Near The Polyadenylation Signal is a Relatively Common, Mild, American Mutation That Masquerades as Sporadic or X‐Linked Recessive Hypophosphatemic Rickets. (January 2015)

4. Severe skeletal toxicity from protracted etidronate therapy for generalized arterial calcification of infancy1. (15th January 2013)

5. Severe skeletal toxicity from protracted etidronate therapy for generalized arterial calcification of infancy1. (15th January 2013)

6. Unique Variant of NOD2 Pediatric Granulomatous Arthritis With Severe 1, 25‐Dihydroxyvitamin D‐Mediated Hypercalcemia and Generalized Osteosclerosis. (30th July 2018)

7. X‐Linked Hypophosphatemia Caused by the Prevailing North American PHEX Variant c.*231A>G; Exon 13–15 Duplication Is Often Misdiagnosed as Ankylosing Spondylitis and Manifests in Both Men and Women. (2nd November 2022)

8. X‐Linked Hypophosphatemia: Uniquely Mild Disease Associated With PHEX 3′‐UTR Mutation c.*231A>G (A Retrospective Case–Control Study). (10th March 2020)